Therapeutic Asset Ratings
19,639 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Epirubicin
Estrogen-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BB
(71)
Epirubicin
Progesterone-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BB
(71)
Epirubicin
Recurrent Mycosis Fungoides
Memorial Sloan Kettering Cancer Center
P2
BB
(71)
ETOPOSIDE
Breast Cancer Diagnosis
Graziella di Grezia
P2
BB
(71)
Fludarabine
Acute Undifferentiated Leukemia
Fred Hutchinson Cancer Center
P2
BB
(71)
Fludarabine
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer Center
P2
BB
(71)
Fludarabine
Hematologic Disorder
Baptist Health South Florida
P2
BB
(71)
FLUDEOXYGLUCOSE
Recurrent Adult Brain Tumor
Algemeen Ziekenhuis Maria Middelares
P2
BB
(71)
FLUOROURACILUM
Cancer Of Unknown Primary Site
Alliance for Clinical Trials in Oncology
P2
BB
(71)
Imatinib
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
The University of Hong Kong
P2
BB
(71)
Irinotecan
Pancreatic Acinar Cell Carcinoma
Artios Pharma Ltd
P2
BB
(71)
Irinotecan
Ovarian Carcinoma
OHSU Knight Cancer Institute
P2
BB
(71)
Letrozole
Stage III Pancreatic Cancer AJCC v8
OHSU Knight Cancer Institute
P2
BB
(71)
Marijuana
Cannabis
Centre hospitalier de l'Université de Montréal (CHUM)
P2
BB
(71)
MOGAMULIZUMAB
Adult T-Cell Leukemia/Lymphoma
Memorial Sloan Kettering Cancer Center
P2
BB
(71)
Monomethyl Fumarate
Accelerated Phase Chronic Myelogenous Leukemia
University of Michigan Rogel Cancer Center
P2
BB
(71)
Monomethyl Fumarate
Blastic Phase Chronic Myelogenous Leukemia
University of Michigan Rogel Cancer Center
P2
BB
(71)
Monomethyl Fumarate
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesota
P2
BB
(71)
Monomethyl Fumarate
Recurrent Adult Lymphoblastic Lymphoma
Fred Hutchinson Cancer Center
P2
BB
(71)
Monomethyl Fumarate
Recurrent Adult T-cell Leukemia/Lymphoma
Thomas Jefferson University
P2
BB
(71)
Monomethyl Fumarate
Recurrent Marginal Zone Lymphoma
Masonic Cancer Center, University of Minnesota
P2
BB
(71)
Monomethyl Fumarate
Relapsed T-Cell Lymphoma
Masonic Cancer Center, University of Minnesota
P2
BB
(71)
Obinutuzumab
Richter Transformation
Christine Ryan
P2
BB
(71)
Pembrolizumab
Estrogen-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BB
(71)
Pembrolizumab
Progesterone-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BB
(71)
Showing 151 to 175 of 19,639 assets
Previous
Page 7 of 786
Next